News

Talk im Cube: Building the bridge from preclinical to clinical studies

13.06.2024 / Join us for the next edition of Talk im Cube

The transition from preclinical studies to human clinical trials is challenging in many ways – scientifically, regulatory and organizationally. Companies need to become even more efficient to get their drugs through the development process.

Panel Discussion:
Building the bridge from preclinical to clinical studies
Proven experts in the field of preclinical and clinical development will introduce into the complexity of the topic and will discuss how to streamline the processes and to minimize risks and pitfalls.

With

Jens Hoffmann, Managing Director of Experimental Pharmacology & Oncology (EPO), Berlin-Buch GmbH,
Michael Firgens, Managing Director at MF Biotech, Berlin,
Virgilio Garcia Lerma, Executive Director, Regulatory Strategy at Worldwide Clinical Trials, Madrid, Spain,
Uwe Lohmeier, Head of Gläsernes Labor Akademie (GLA), Campus Berlin-Buch GmbH (Moderation)

Key Topics:

• Reflect clinical problems in preclinical models,
• Balance in vitro, animal and human experimentation from an ethical point of view,
• Comply with regulatory requirements such as ICH, EMA, FDA etc.,
• Remain financially successful.

When: 13 June 2024, 5pm
Where: Campus Berlin-Buch, BerlinBioCube

Don’t miss the opportunity to join in the discussion and exchange ideas with each other and our experts over snacks and drinks at the subsequent get-together and networking
event.

 

Quelle: Gläsernes Labor Akademie
Registration is requested